Helen Floersh

Staff Reporter (Healthcare, Law, Biotech)

Helen covers healthcare, law, insurance and biotechnology in the greater Valley region.

Email: hfloersh@sfvbj.com
Phone: 818-316-3121 Extension: 112

Recent Stories

Workers Stage Picket at Providence Tarzana

About 100 employees of Providence Tarzana Medical Center turned out for a picket yesterday to protest what they described as unfair labor practices.

Five Arrested in Valley Health Insurance Fraud

Five people were arrested and charged on Tuesday with conducting a health insurance fraud scheme that involved patients at a pair of medical spas in the San Fernando Valley.

Amgen Migraine Drug Gets FDA Approval

Amgen Inc.’s drug Aimovig has received Food and Drug Administration approval for the prevention of migraines in adults, the first drug of its kind to do so.

Pfizer Gets FDA Approval for Amgen Biosimilar

The Food and Drug Administration has approved Pfizer’s application for Retacrit, a biosimilar of Amgen Inc. and Johnson & Johnson’s anemia drug Epogen.

Adventist Health Glendale Appoints New President

Adventist Health has appointed Alice Issai as president of Adventist Health Glendale, the hospital system announced Monday.

Outpatient Networks a New Reality for Hospitals

LIST: Cost factors drive collaboration with clinics and doctor groups.

Local hospitals harness power of physician networks.

Court Redefines Indy Contractor

LAW: Decision could impact outside sales forces in state.

Dynamex decision discerns between independent contractors and employees.

Eyenuk Foresees Market Expansion With Funds

SOFTWARE: $3 million will commercialize company’s EyeArt screening product.

Eyenuk gets financing for EyeArt expansion.

MannKind Moves Past Risk Disclosure Issue

BIOTECH: FDA decision could free resources for improving Afrezza sales.

MannKind stock swings on earnings, FDA news.

Preview: Outpatient Networks a New Reality for Hospitals

Cost factors drive collaboration with clinics and doctor groups.

More stories >>